Treatment options in hormone-sensitive prostate cancer: targeting the androgen-sensitive pathway.
This publication reviews the treatment of hormone-sensitive prostate cancer (HSPC), focusing on therapies targeting the...
Evaluation of prostate cancer pathology reports generated by ChatGPT to enhance patient comprehension.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:1 min read
This quality improvement study assessed the use of ChatGPT-3.5 to translate prostate cancer pathology reports into patie...
State-of-the-Art Imaging in Antibody-Drug Conjugate Treatment for Advanced Bladder Cancer.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:1 min read
This review focuses on the transformative impact of antibody-drug conjugates (ADCs), specifically enfortumab vedotin and...
Germline Testing: The Therapeutic Biomarker You Can’t Afford to Miss
- Post category:Breast Cancer/Digestive (CRC, Stomach) System/Genitourinary (Prostate, Bladder) System/Gynecologic Cancer/Melanoma/Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
You may already be ordering germline testing at rates well above the national average — but across the U.S., most eligible patients still aren’t tested: Ovarian cancer: ~39% receive germline…
Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:1 min read
This publication reviews the rapidly evolving management of muscle-invasive bladder cancer (MIBC), highlighting the crit...
Muscle-Invasive Bladder Cancer: A Watershed Moment.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:1 min read
The management of muscle-invasive bladder cancer (MIBC) has significantly advanced, particularly recognizing the challen...